ELLIOT SIGAL Insider Trading
Get free email notifications about insider trading for ELLIOT SIGAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ELLIOT SIGAL. ELLIOT SIGAL is a CSO & President PRI in BRISTOL MYERS SQUIBB CO ($BMY) and a EVP, CSO & President PRI in BRISTOL MYERS SQUIBB CO ($BMY) and a EVP, CSO & President R&D in BRISTOL MYERS SQUIBB CO ($BMY) and a SVP, Global Clin & Pharm Dev in BRISTOL MYERS SQUIBB CO ($BMY) and a Director in Mead Johnson Nutrition Co ($MJN) and a Director in Spark Therapeutics, Inc. ($ONCE).
Address: BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCELINE ROAD PRINCETON 08540 NJ
Companies in which ELLIOT SIGAL is an Insider
BRISTOL MYERS SQUIBB CO
Trading Symbol: BMYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ELLIOT SIGAL: EVP, CSO & President R&D, EVP, CSO & President PRI, CSO & President PRI, SVP, Global Clin & Pharm Dev
Holdings: 165,493 shares
Current Value: $8,549,368
Latest Transaction: Mar 06 2008
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mead Johnson Nutrition Co
Trading Symbol: MJNIndustry: FOOD & KINDRED PRODUCTS [2000]
Position of ELLIOT SIGAL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2017
$MJN Market Capitalization: $15.46B
$MJN Previous Close: $83.87
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Spark Therapeutics, Inc.
Trading Symbol: ONCEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ELLIOT SIGAL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 17 2019
$ONCE Market Capitalization: $2.00B
$ONCE Previous Close: $63.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ELLIOT SIGAL
Sentiment: All, BMY, MJN, ONCE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 25,786 | 88,962 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 17,203 | 59,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 25,786 | 88,962 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 17,203 | 59,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 |